Skip to results
Modify your search
NARROW
1-4 of 4
Authors: Andreas Lazar
Journal Article
Bridging Fixed Dose to Body Weight-based Regimen of Adalimumab in Paediatric Ulcerative Colitis Using a Pharmacometric Modelling Approach: Case Study with the Phase 3 ENVISION I Trial
Journal of Crohn's and Colitis, Volume 16, Issue 10, October 2022, Pages 1551–1561, https://doi.org/10.1093/ecco-jcc/jjac066
Published: 08 May 2022
Journal Article
Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: A Pooled Analysis From Patients With Ulcerative Colitis in Two Clinical Trials
Journal of Crohn's and Colitis, Volume 13, Issue 9, September 2019, Pages 1227–1233, https://doi.org/10.1093/ecco-jcc/jjz031
Published: 07 February 2019
Journal Article
Efficacy of Adalimumab for Treatment of Perianal Fistula in Children with Moderately to Severely Active Crohn’s Disease: Results from IMAgINE 1 and IMAgINE 2
Journal of Crohn's and Colitis, Volume 12, Issue 10, October 2018, Pages 1249–1254, https://doi.org/10.1093/ecco-jcc/jjy087
Published: 22 June 2018
Journal Article
Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA
Journal of Crohn's and Colitis, Volume 11, Issue 11, November 2017, Pages 1317–1325, https://doi.org/10.1093/ecco-jcc/jjx093
Published: 17 July 2017
